Quality business in tactically unfavorable position; patient HOLD with $119 stop and $121-$125 re-entry zone
HOLD is the only defensible execution. Aggressive BUY fails on three counts: (1) re-rating to 35-50x forward earnings requires demonstrated Armis integration success not yet proven; (2) proposed $121 stop is only 1.16x ATR away, getting chopped on routine single-session volatility — making "2.4:1 R/R" mathematically dishonest; (3) NOW has already demonstrated 58% de-rating ($194.73 to $81.24), making directional optionality symmetric, not asymmetric to upside. Conservative trim/Underweight overstates M&A risk — net debt ≈ 1 year of FCF at $5.15B TTM FCF is manageable. Existing position with $119 stop (1.5x ATR — properly positioned for volatility regime) already captures AI orchestration re-rating upside without fresh capital deployment at $128. Bull targets ($134-$150) offer +4.6% to +17% upside against -15% to 50 SMA downside and -28% to July lows — asymmetric risk to the downside makes M&A integration risk, leverage risk (debt 3.5x QoQ), competitive risk (CRM agentic AI, MSFT Copilot bundling, PLTR data orchestration), and technical overextension non-compelling. The current setup is materially closer to the successful 2026-08-19 Hold ($127.20, +2.8% alpha) than the failed 2026-08-14 Hold ($124, -4.6% alpha) — HOLD with operational triggers respects both the elite franchise and the unfavorable tactical position.
| Position | Action |
|---|---|
| Price reaches $121-$125 on pullback to 10 EMA / Bollinger middle cluster | Consider re-entry / adding to position |
| Price approaches or breaches $119 stop | Exit existing position |
| Q3 2026 earnings (late October) | Re-evaluate thesis for potential re-rate to $150+ zone |
NOW is a high-quality compounder at an inflection point: revenue accelerating to 24% YoY, FCF growing faster than revenue at 27.7% CAGR, deferred revenue of $8.19B locking in future visibility, AI positioning as an enterprise orchestration layer validated by Tech Mahindra and Tribal partnerships, all trading at a forward PE of 25.6x with a PEG of 1.15 and 3.9% FCF yield after a 41% rally off the lows—making this a BUY with $145-150 target.
| Indicator | Value | Signal |
|---|---|---|
| close_10_ema | 124.99 | bullish |
| close_50_sma | 109.42 | bullish |
| close_200_sma | 120.06 | bullish |
| rsi | 61.80 | bullish |
| macd | 5.36 | bullish |
| macds | 5.08 | bullish |
| macdh | 0.28 | bullish |
| vwma | 123.86 | bullish |
| boll_middle | 121.07 | neutral |
| boll_ub | 134.28 | neutral |
| boll_lb | 107.85 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Q3 2026 earnings (late October) resolves M&A integration question with demonstrated Armis integration success
Then: Re-evaluate for potential upgrade to BUY with $150+ price target
Deferred revenue of $8.19B growing 18.5% YoY represents contracted, cash-paid future revenue that locks in the next 12 months of visibility regardless of macro
EV: +$145-150 (post-crash gap-fill zone and early-2026 resistance cluster); +$134 intermediate target (Bollinger upper band) · concedes: M&A risk is real—$8B goodwill jump and leverage spiked to 1.7x Net Debt/EBITDA—but $5.15B TTM FCF covers $5.0B net debt comfortably; Bear concerns on mean reversion (stretched 17% above still-falling 50 SMA) are technically valid but price extensions in real recoveries are normal and healthy; SGA letter raising capital allocation concerns is a data point worth weighting, though the business fundamentals don't bend to one fund's view; Latest session volume of 8.93M was light—pullbacks on light volume in uptrends are healthy but confirm volume hasn't yet confirmed the breakout; Forward PE of 25.6x is not cheap in absolute terms, though PEG of 1.15 represents fair value for this quality of compounder
NOW's "V-shaped recovery" is a bear-market rally in a fundamentally deteriorating setup—the apparent acceleration is M&A-inflated, the technical setup shows buyer exhaustion, and the valuation offers no margin of safety against defined downside risks.
EV: -$92-95 (bear) vs +$145-150 (bull) · concedes: Fed not raising rates removes upside de-rating tail risk; 24% YoY revenue growth is real (though inorganic); V-shaped recoveries do occasionally succeed; Macro uncertainty could resolve favorably; Some institutional long-only holders remain supportive
→ vs conservative: Asymmetry math argument anchors on near-term noise; dismissing NOW as single-digit upside at $128 misprices the optionality of owning the enterprise AI orchestration layer
→ vs conservative: Goodwill/debt expansion framing is 'flinching at the headline'; actual math shows $5.15B FCF vs $5B net debt = one year payback, not a leverage red flag
→ vs conservative: Volume divergence on Aug 24 (8.93M shares) is classic consolidation on declining volume after sharp move—a continuation pattern, not a reversal signal
→ vs conservative: Stop at $119 with $9 risk per share on beta 0.93 name with $6 ATR should allow position sizing to capture the move, not 'trim to oblivion'
→ vs neutral: HOLD framing as 'fresh capital deployment not justified' is wrong for moderate or below-average exposure; BUY with tight stop at $121 is appropriate
→ vs neutral: Technical overextension concern ignores RSI 61.8 (mid-bullish with room), MACD expanding, and constructive scenario calling for move to $134 on close above $130
→ vs neutral: Patient re-entry narrative is 'most dangerous' framing; protection without capture is 'mediocrity dressed up as discipline'
→ vs neutral: PLTR outperforming NOW one day doesn't mean capital rotating out; healthy sector dispersion, not rejection of NOW thesis
| atr | 6.00 | bearish |
Support: 107.85 · 109.42 · 120.06 | Resistance: 129.75 · 134.28
ServiceNow shows a short-term constructive bias with price at 128.05 trading above all three major moving averages for the first time since December 2025, supported by bullish momentum (RSI 61.80, MACD above signal). However, the stock is extended 17% above the still-falling 50 SMA and elevated ATR of 6.00 (~4.7% of price) indicates high volatility requiring wider stops. Key resistance at 129.75-130 and Bollinger upper band at 134.28; key support at 121.07 (Bollinger middle) and 107.85 (Bollinger lower). Overall bias is tactical long but disciplined risk management warranted given the recovery-phase long-term trend structure.
Market Cap
$132.39B
Stock Price
~$128
52-Week High
$194.73
52-Week Low
$81.24
50-Day Moving Average
$108.92
200-Day Moving Average
$120.31
Beta
0.93
PE Ratio (TTM)
79.5
Forward PE
25.6
PEG Ratio
1.15
Price / Book
10.58
Book Value / Share
$12.11
Q2 2025 Revenue
$3,215M
Q2 2025 Gross Profit
$2,491M
Q2 2025 Operating Income
$358M
Q2 2025 Net Income
$385M
Q2 2025 Diluted EPS
$0.368
Q3 2025 Revenue
$3,407M
Q3 2025 Gross Profit
$2,633M
Q3 2025 Operating Income
$572M
Q3 2025 Net Income
$502M
Q3 2025 Diluted EPS
$0.48
Q4 2025 Revenue
$3,568M
Q4 2025 Gross Profit
$2,734M
Q4 2025 Operating Income
$443M
Q4 2025 Net Income
$401M
Q4 2025 Diluted EPS
$0.38
Q1 2026 Revenue
$3,770M
Q1 2026 Gross Profit
$2,830M
Q1 2026 Operating Income
$503M
Q1 2026 Net Income
$469M
Q1 2026 Diluted EPS
$0.45
Q2 2026 Revenue
$3,987M
Q2 2026 Gross Profit
$2,818M
Q2 2026 Operating Income
$162M
Q2 2026 Net Income
$298M
Q2 2026 Diluted EPS
$0.29
FY2022 Revenue
$7,245M
FY2022 YoY Growth
—
FY2022 Gross Profit
$5,672M
FY2022 Gross Margin
78.3%
FY2022 Operating Income
$355M
FY2022 Operating Margin
4.9%
FY2022 Net Income
$325M
FY2022 Diluted EPS
$0.32
FY2023 Revenue
$8,971M
FY2023 YoY Growth
+23.8%
FY2023 Gross Profit
$7,050M
FY2023 Gross Margin
78.6%
FY2023 Operating Income
$762M
FY2023 Operating Margin
8.5%
FY2023 Net Income
$1,731M
FY2023 Diluted EPS
$1.68
FY2024 Revenue
$10,984M
FY2024 YoY Growth
+22.4%
FY2024 Gross Profit
$8,697M
FY2024 Gross Margin
79.2%
FY2024 Operating Income
$1,364M
FY2024 Operating Margin
12.4%
FY2024 Net Income
$1,425M
FY2024 Diluted EPS
$1.37
FY2025 Revenue
$13,278M
FY2025 YoY Growth
+20.9%
FY2025 Gross Profit
$10,295M
FY2025 Gross Margin
77.5%
FY2025 Operating Income
$1,824M
FY2025 Operating Margin
13.7%
FY2025 Net Income
$1,748M
FY2025 Diluted EPS
$1.67
Q2 2026 Total Assets
$31,666M
Q2 2025 Total Assets
$22,051M
Total Assets Change
+43.6%
Q2 2026 Cash & ST Investments
$4,664M
Q2 2025 Cash & ST Investments
$6,132M
Cash Change
-23.9%
Q2 2026 Goodwill & Intangibles
$13,618M
Q2 2025 Goodwill & Intangibles
$2,097M
Goodwill Change
+549%
Q2 2026 Total Debt
$8,453M
Q2 2025 Total Debt
$2,409M
Debt Change
+251%
Q2 2026 Stockholders' Equity
$12,516M
Q2 2025 Stockholders' Equity
$10,932M
Equity Change
+14.5%
Q2 2026 Current Deferred Revenue
$8,057M
Q2 2025 Current Deferred Revenue
$6,802M
Current Deferred Revenue Change
+18.5%
Q2 2026 Long-Term Deferred Revenue
$135M
Q2 2025 Long-Term Deferred Revenue
$110M
LT Deferred Revenue Change
+22.7%
Q2 2025 Operating Cash Flow
$716M
Q3 2025 Operating Cash Flow
$813M
Q4 2025 Operating Cash Flow
$2,238M
Q1 2026 Operating Cash Flow
$1,670M
Q2 2026 Operating Cash Flow
$587M
Q2 2025 CapEx
-$190M
Q3 2025 CapEx
-$244M
Q4 2025 CapEx
-$238M
Q1 2026 CapEx
-$141M
Q2 2026 CapEx
-$114M
Q2 2025 Free Cash Flow
$526M
Q3 2025 Free Cash Flow
$569M
Q4 2025 Free Cash Flow
$2,000M
Q1 2026 Free Cash Flow
$1,529M
Q2 2026 Free Cash Flow
$473M
Q2 2025 Buybacks
-$361M
Q3 2025 Buybacks
-$584M
Q4 2025 Buybacks
-$597M
Q1 2026 Buybacks
-$2,225M
Q2 2026 Buybacks
$0
FY2022 Operating Cash Flow
$2,723M
FY2023 Operating Cash Flow
$3,398M
FY2024 Operating Cash Flow
$4,267M
FY2025 Operating Cash Flow
$5,444M
FY2022 CapEx
-$550M
FY2023 CapEx
-$697M
FY2024 CapEx
-$892M
FY2025 CapEx
-$911M
FY2022 Free Cash Flow
$2,173M
FY2023 Free Cash Flow
$2,701M
FY2024 Free Cash Flow
$3,375M
FY2025 Free Cash Flow
$4,533M
FY2022 FCF Margin
30.0%
FY2023 FCF Margin
30.1%
FY2024 FCF Margin
30.7%
FY2025 FCF Margin
34.1%
FY2022 Buybacks
$0
FY2023 Buybacks
-$538M
FY2024 Buybacks
-$696M
FY2025 Buybacks
-$1,840M
TTM FCF
$5.15B
TTM Gross Margin
74.8%
TTM Operating Margin
4.06%
TTM Net Profit Margin
11.3%
ROE
14.2%
ROA
4.2%
FCF Yield
~3.9%
Debt / Equity
67.5
Current Ratio
0.70
Net Debt
$5.01B
Revenue YoY (Q2'26)
+24.0%
Revenue 4Y CAGR
~22.4%
FCF 4Y CAGR
~27.7%
EPS Forward
$5.01
Q2 2026 R&D Spend
$915M
Q2 2026 S&M Spend
$1.37B
M&A Purchase of Business
$7.45B
Commercial Paper
$2.08B
Long-Term Debt
$5.44B
FY2023 One-Time Tax Benefit
$857M
Net Debt / EBITDA
~1.7x
Strengths
Concerns
ServiceNow is a premium SaaS compounder with ~22-24% revenue growth at $13.3B+ annual scale, elite 34% FCF margins generating $5.15B TTM FCF, and a massive $8.2B deferred revenue backlog providing strong revenue visibility. The company demonstrated remarkable operating leverage over 4 years (Op margin: 4.9% → 13.7%) with a highly recurring 96% subscription model. However, a $7.45B M&A deal in Q2'26 nearly doubled goodwill to $13.6B and pushed net debt to $5.0B, creating integration and leverage risks alongside the stock's ~33% drawdown from its 52-week high. At ~25.6x forward PE with ~1.15 PEG ratio, the stock appears fairly valued to slightly undervalued for quality-conscious long-term investors, though traders should monitor Q3'26 earnings for revenue growth maintenance and M&A integration updates.
Macro: Benign macro backdrop for high-multiple software: Polymarket pricing in 86% probability of no Fed cuts in 2026 (+1.2pp 1-week), with 0% odds of 6+ or 9/10/12+ cuts; US recession odds at just 8% for end of 2026 ($1.7M traded volume); commodities showing mild risk-on with gold at $4,640.80 (+0.36%) and silver up 18% MoM; Morningstar S&P 500 8,000 call names software (CRM, NOW, WDAY, MSFT) as August rebound leaders; broader equity tape showing software sector rebound from YTD lows with BofA constructive on the space.